Guidelines
The GOC Guidelines are statements that provide recommendations for the diagnosis, treatment, or prevention of gynecologic cancers based on the best available evidence and expert consensus.
Current Oncology | Free Full-Text
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia (mdpi.com)
Lignes directrices canadiennes sur la colposcopie
Une approche de la prise en charge et de la surveillance de la dysplasie du col de l’utérus fondée sur le risque, 2023
Current Oncology | Free Full-Text
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations (mdpi.com)
Lignes directrices canadiennes
Sur la prise en charge des personnes ayant obtenu un résultat positif au test de détection des virus du papillome humain et orientations pour certaines populations
Current Oncology | PDF Download
HPV Testing, Self-Collection, and Vaccination: A Comprehensive Approach to Cervical Cancer Prevention
Upcoming Events
2026
- CPD - Toronto, Ont April 23 & 24
- AGM - Ottawa, Ont June 19-20
Toolkit
Molecular Diagnostic Toolkit Endometrial & Vulvar Cancer
Guide
Ovarian cancer occurs from the growth of cancer cells that form in the ovaries.
Position Statements
Our position statements express the opinions of GOC on a variety of topics or issues related to gynecologic oncology. They are all based on evidence, research, and expert consensus, and they aim to provide guidance, recommendations, and gynecologic oncology standards.
CA 125 Monitoring in the Management of Recurrent Ovarian Cancer
Results of a multi-institutional European trial comparing early treatment of relapsed ovarian cancer based on CA125 only versus delayed treatment based on conventional clinical indicators after completion of first line chemotherapy, was presented at the American Society of Clinical Oncology meeting (ASCO) on May 31st.
English 
French